Evaluation of oxidative stress markers and vascular risk factors in patients with diabetic peripheral neuropathy

Cell Biochemistry and Function

Volumn 30, Issue 4, 2012, Pages 328-334

  El Boghdady, Noha Ahmed ^a   Badr, Gamal Ali ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b AL AZHAR UNIVERSITY   (Egypt)

Author keywords

glutamyl transferase; Ceruloplasmin; Endothelin 1; Glutathione; Homocysteine; Malondialdehyde; Nitrite nitrate; Total antioxidants

Indexed keywords

CERULOPLASMIN; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; GLYCOSYLATED HEMOGLOBIN; HOMOCYSTEINE; INSULIN; MALONALDEHYDE; NITRITE; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; BIOCHEMISTRY; CARDIOVASCULAR RISK; CERULOPLASMIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIABETIC PERIPHERAL NEUROPATHY; ENZYME BLOOD LEVEL; ERYTHROCYTE; FEMALE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL;

ADULT; AGED; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; ERYTHROCYTES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GLUTATHIONE; HEMOGLOBIN A, GLYCOSYLATED; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PREVALENCE; PROGNOSIS; RISK FACTORS;

EID: 84861956442     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.2808     Document Type: Article

References (50)

1. Biessels GJ, Ter Laak MP, Kamal A, Gispen WH. Effects of the Ca2+ antagonist nimodipine on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats. Brain Res 2005; 1035: 86-93.
2. Savelberg HH, Schaper NC, Willems PJ, De Lange TL, Meijer K. Redistribution of joint moments is associated with changed plantar pressure in diabetic polyneuropathy. BMC Musculoskelet Disord 2009; 10: 16-26.
3. Zochodne DW. Diabetic polyneuropathy: an update. Curr Opin Neurol 2008; 21: 527-533.
4. Dellon AL. Diabetic neuropathy: review of a surgical approach to restore sensation, relieve pain, and prevent ulceration and amputation. Foot Ankle Int 2004; 25: 749-755.
5. Vinik AI, Park TS, Stansberry KB, Pittenger GL. Diabetic neuropathies. Diabetologia 2000; 43: 957-973.
6. Maritim AC, Sanders RA, Watkins JB. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003; 17: 24-38.
7. Heistad Donald D. Oxidative Stress and Vascular Disease. Arterioscler Thromb Vasc Biol 2005; 26: 689-695.
8. Ashour M, Salem S, Hassaneen H, et al. Antioxidant status and insulin dependent diabetes mellitus (IDDM). J Clin Biochem Nutr 1999; 26: 99-107.
9. Giampiero M, Cotroneo P, Pitocco D, et al. Early Increase of Oxidative Stress and Reduced Antioxidant Defenses in Patients with Uncomplicated Type 1 Diabetes. Diabetes Care 2002; 25: 370-375.
10. Lee DH, Jacobs DR, Gross M, et al. Gamma glutamyltransferase is a predictor of incident diabetes and hypertension: the CARDIA study. Clin Chem 2003; 49: 1358-1366.
11. Lee DH, Steffen LM, Jacobs DR. Association between serum gamma-glutamyltransferase and dietary factors: CARDIA study. Am J Clin Nutr 2004; 79: 600-605.
12. Garofolo L, Barros N, Jr, Miranda F, Jr, D'almeida V, Cardien LC, Ferreira SR. Association of increased levels of homocysteine and peripheral arterial disease in a Japanase-Brazilian population. Eur J Vasc Endovasc Surg 2007; 34: 23-28.
13. Pradham AD, Shrivastavas S, Cook NR, Rifai N, Creager MA, Ridker PM. Symptomatic peripheral arterial disease in women: non-traditional biomarkers of elevated risk. Circulation 2008; 117: 823-831.
14. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008; 31(Suppl. 1): S55-S60.
15. Jung YS, Lee KY, Lee SK, Kim HK, Park HY, Kang MH. Peripheral polyneruopathy and hypoinsulinemia in patients with type 2 diabetes. J Korean Diabetes Assoc 2000; 24: 256-266.
16. Varley H, Gowenlock AH, Bell M. Non protein, urea, ureate, creatine and creatinine. In practical clinical biochemistry, Vol. 1 (5th edn), Heinnemann W (ed.) Medical books Ltd: London, 1980; 479-485.
17. Schosinsky KH, Lehmann HP, Beeler MF. Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride. Clin Chem 1974; 20(12): 1556-1563.
18. Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963; 61: 882-888.
19. Uchiyama M, Mihara M. Determination of malondialdehyde precursor in tissue by thiobarbituric acid method. Anal Biochem 1978; 86: 271-278.
20. Braman RS, Hendrix SA. Nanogram nitrite and nitrate determination in environmemtal and biological materials by vanadium (III) reduction with chemiluminescence detection. Anal Chem 1989; 61: 2715-2718.
21. Figueroa-Romero C, Sadidi M, Feldman EL. Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord 2008; 9: 301-314.
22. Edwards JL, Vincent AM, Cheng HT, Feldman EL. Diabetic neuropathy: mechanisms to management. Pharmacol Ther 2008; 120: 1-34.
23. Sakurai K, Haga K, Ogiso T. A role of iron in lambda DNA strand breaks in the reaction system of alloxan with reduced gluthathione: Iron(III) binding to the DNA. Biol Pharm Bull 1994; 17: 227-231.
24. Spear N, Aust SD. Thiol-mediated NTA-Fe(III) reduction and lipid peroxidation. Arch Biochem Biophys 1994; 312: 198-202.
25. Pasaoglu H, Sancak B, Bukan N. Lipid peroxidation and resistance to oxidation in patients with type 2 diabetes mellitus. Tohoku J Exp Med 2004; 203(3): 211-218.
26. Healy J, Tipton K. Ceruloplasmin and what it might do. J Neural Transm 2007; 114: 777-781.
27. Correale M, Brunetti ND, De Gennaro L, Di Biase M. Acute phase proteins in atherosclerosis (acute coronary syndrome). Cardiovasc Hematol Agents Med Chem 2008; 6: 272-277.
28. Memisogullari R, Bakan E. Levels of ceruloplasmin, transferrin, and lipid peroxidation in the serum of patients with Type 2 diabetes mellitus. J Diabetes Complicat 2004; 18: 193-197.
29. Srivatsan R, Das S, Gadde R, et al. Antioxidants and lipid peroxidation status in diabetic patients with and without complications. Arch Iran Med 2009; 12: 121-127.
30. Martin-Gallan P, Carrascisa A, Gussinye M, Dominguez C. Estimation of lipoperoxidative damage and antioxidant status in diabetic children: relationship with individual antioxidants. Free Radic Res 2005; 39: 933-942.
31. Astaneie F, Afshari M, Mojtahedi A, et al. Total antioxidant capacity and levels of epidermal growth factor and nitric oxide in blood and saliva of insulin dependent diabetic patients. Arch Med Res 2005; 36: 376-381.
32. The Diabetes Control and Complications Trial Research Group. Factors in the development of diabetic neuropathy: baseline analysis of neuropathy in the feasibility phase of the diabetes complications trial (DCCT). Diabetes 1988; 37: 476-481.
33. De Sonnaville JJ, Bouma M. Sustained good control in NIDDM patients by implementation of structured care in general practice: 2-year follow-up study. Diabetologia 1997; 40: 1334-1340.
34. Devaraj S, Jialal I. Antioxidants and vitamins to reduce cardiovascular disease. Curr Atheroscler Rep 2000; 2: 342-351.
35. Mohan IK, Das UN. Oxidant stress, antioxidants and nitric oxide in NIDDM. Med Sci Res 1997; 25: 55-57.
36. Kim JE, Kim AR, Chung HY, Han SY, Kim BS, Choi JS. In vitro peroxynitrite scavenging activity of diarylheptanoids from Curcuma longa. Phytother Res 2003; 17: 481-484.
37. Kuhad A, Sharma S, Chopra K. Lycopene attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. Eur J Pain 2008; 12: 624-632.
38. Yanagisawa M, Masaki T. Molecular biology and biochemistry of the endothelins. Trends Pharmacol Sci 1989; 10: 374-378.
39. Levin ER. Endothelins. N Engl J Med 1995; 333: 356-363.
40. Takahashi K, Ghatei MA, Lam HC, O'Halloran DJ, Bloom SR. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 1990; 33: 306-310.
41. Kakizawa H, Itoh M, Itoh Y, et al. The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diadetic patients. Metabolism 2004; 53: 550-555.
42. Bruce SG, Young TK. Prevalence and risk factors for neuropathy in a Canadian First Nation community. Diabetes Care 2008; 31: 1837-1841.
43. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, et al. Adverse vascular effects of homocysteine are modulated by endothelial-derived relaxing factor and related oxides of nitrogen. Clin Invest 1993; 91: 308-318.
44. Kugelman A, Choy HA, Liu R, Shi MM, Gozal E, Forman HJ. gamma-Glutamyl transpeptidase is increased by oxidative stress in rat alveolar L2 epithelial cells. Am J Resp Cell Mol Biol 1994; 11: 586-592.
45. Zalata A, Hafex T, Mahmoud A, Comhaire F. Relationship between resazurin reduction test, reactive oxygen species generation, and gamma-glutamyltransferase. Hum Reprod 1995; 10: 1136-1140.
46. Glass GA, Stark AA. Promotion of glutathione-gammaglutamyl transpeptidase-dependent lipid peroxidaftion by copper and ceruloplasmin: the requirement for iron and the effects of antioxidants and antioxidant enzymes. Environ Mol Mutagen 1997; 29: 73-80.
47. Drozdz R, Parmentier C, Hachad H, Leroy P, Siest G, Wellman M. g-Glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system. Free Radic Biol Med 1998; 25: 786-792.
48. Sakuta H, Suzuki T, Ito T. Serum glutamyl transferase is associated with plasma total homocysteine in Japanese patients with type 2 diabetes. Acta Diabetol 2007; 44(4): 177-180.
49. Arkkila PE, Koskinen PJ, Kantola IM, Rönnemaa T, Seppänen E, Viikari JS. Diabetic complications are associated with liver enzyme activities in people with type 1 diabetes. Diabetes Res Clin Pract 2001; 52(2): 113-118.
50. Cho HC. The Association between Serum GGT Concentration and Diabetic Peripheral Polyneuropathy in Type 2 Diabetic Patients. Korean Diabetes J 2010; 34(2): 111-118.